Consumers Can Now Buy a Blood Test to Evaluate Their Alzheimer Disease Risk, but Should They?

JAMA. 2023 Oct 3;330(13):1214-1216. doi: 10.1001/jama.2023.17685.
No abstract available

Plain language summary

This Medical News feature discusses a Quest Diagnostics blood biomarkers test that is supposed to help consumers assess their Alzheimer disease risk.

MeSH terms

  • Alzheimer Disease* / blood
  • Alzheimer Disease* / diagnosis
  • Alzheimer Disease* / epidemiology
  • Consumer Behavior
  • Disease Susceptibility / blood
  • Disease Susceptibility / diagnosis
  • Disease Susceptibility / epidemiology
  • Hematologic Tests* / methods
  • Humans
  • Risk
  • Self-Testing*